SHPA standards of practice for pharmacy investigational drugs services

Journal of Pharmacy Practice and Research

Volumn 36, Issue 1, 2006, Pages 46-52

  Hynes, Kay ^a   Davis, Jillian ^a   Kopp, Helen ^a   Morris, Angela ^a   Rice, Carol ^a   Matthews, Helen ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PHARMACY; CLINICAL PRACTICE; CONFIDENTIALITY; DRUG COST; DRUG INFORMATION; DRUG MANUFACTURE; DRUG SCREENING; DRUG STORAGE; DRUG SURVEILLANCE PROGRAM; DRUG USE; ETHICS; EXPIRATION DATE; HEALTH CARE POLICY; HUMAN; INFORMATION DISSEMINATION; INFORMATION STORAGE; INFORMED CONSENT; PATIENT COUNSELING; PHARMACIST; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; QUALITY CONTROL; REVIEW; STAFF TRAINING; STANDARDIZATION;

EID: 33646525197     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2006.tb00887.x     Document Type: Review

References (22)

1. The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Investigational Drugs. SHPA standards of practice for pharmacy investigational drugs services. Aust J Hosp Pharm 1999; 29: 227-35.
2. Therapeutic Goods Administration. Access to unapproved drugs via the Special Access Scheme. Canberra: Australian Government Department of Health and Ageing; 2004.
3. The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Clinical Pharmacy. SHPA standards of practice for clinical pharmacy, J Pharm Pract Res 2005; 35: 122-33.
4. Therapeutic Goods Administration. Note for guidance on good clinical practice (CPMPTCH/135/95). Annotated with TGA comments. Canberra: Commonwealth Department of Health and Aged Care; 2000.
5. Therapeutic Goods Administration. Access to unapproved drugs-clinical trials in Australia. Canberra: Department of Health and Ageing; 2004.
6. National Health and Medical Research Council. National statement on ethical conduct in research involving humans. Canberra: Commonwealth of Australia; 1999.
7. National Health and Medical Research Council. The regulation of health information privacy in Australia. Canberra: Commonwealth of Australia; 2004.
8. National Coordinating Committee on Therapeutic Goods. Standards for the preparation of pharmaceuticals in Australian hospital pharmacy departments. Aust J Hosp Pharm 1994; 24: 182-8.
9. Therapeutic Goods Administration. Australian code of good manufacturing practice for medicinal products (Annex 13, Manufacture of investigational medicinal products). Canberra: Department of Health and Ageing; 2002.
10. The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Oncology. SHPA standards of practice for the safe handling of cytotoxic drugs in pharmacy departments. J Pharm Pract Res 2005; 35: 44-52.
11. The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Oncology. SHPA standards of practice for the transportation of cytotoxic drugs from pharmacy departments. Aust J Hosp Pharm 2000; 30: 116-7.
12. Therapeutic Goods Administration. Human research ethics committees and the therapeutic goods legislation. Canberra: Department of Health and Aged Care; 2001.
13. Therapeutic Goods Administration. The Australian clinical trial handbook. Canberra: Australian Government Department of Health and Ageing; 2006.
14. National Health and Medical Research Council. Values and ethics-guidelines for ethical conduct in Aboriginal and Torres Strait Islander health research. Canberra: Commonwealth of Australia; 2003.
15. EQUIP standards and guidelines. 3rd ed. Sydney: The Australian Council on Healthcare Standards; 2002.
16. SAA Joint Technical Committee CH/26, Safety in Laboratories. Australian/New Zealand Standard AS/NZS 2243.3: Safety in Laboratories Part 3: Microbiological aspects and containment facilities. Sydney: ASNZS. 2243.3: 2002/Amdt 1:2003.
17. Richmond JY, McKinney RW, editors. Bio-safety in microbiological and biomedical laboratories. 3rd ed. Washington DC: US Government Printing Office; 1993.
18. DeCederfelt HJ, Grimes GJ, Green L, DeCederfelt RO, Daniels CE. Handling of gene-transfer products by the national institutes of health clinical centre pharmacy department. Am J Health Syst Pharm 1997; 54: 1604-10.
19. Armitstead JA, Zillich AJ, Williams KL, Sitzlar SC, Wermeling D. Hospital and pharmacy departmental policies and procedures for gene therapy at a teaching institution. Hosp Pharm 2001; 36: 56-66.
20. Simpson J, Stoner NS. Implications of gene therapy for hospital pharmacists. Pharm J 2003; 271: 127-30.
21. Department of Health and Ageing. Office of the gene technology regulator. Canberra. Australia. Available at 〈www.ogtr.gov.au/pubform/handbook. htm〉.
22. Department of Human Services and Health. Australian Code of Good Radiopharmaceutical Practice (draft). Canberra: Australian Government Department of Health and Ageing; 1996.